| Database ID | Agent | Target | Cancer Type | Detail |
| DB00781 | crizotinib | Hepatocyte growth factor receptor, ALK, ROS1 | non small cell lung cancer | view |
| DB00782 | cetuximab | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00783 | bevacizumab | Vascular endothelial growth factor | non small cell lung cancer | view |
| DB00784 | gefitinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00785 | pemetrexed | Thymidylate synthase | non small cell lung cancer | view |
| DB00786 | gefitinib | Epidermal growth factor receptor | lung cancer | view |
| DB00787 | gefitinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00788 | erlotinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00789 | gefitinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00790 | veliparib | Poly [ADPribose] polymerase1 | smallcell lung cancer | view |
| DB00791 | linifanib | Macrophage colonystimulating factor 1 | non small cell lung cancer | view |
| DB00792 | cetuximab | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00793 | everolimus | Serine/threonineprotein kinase mTOR | non small cell lung cancer | view |
| DB00794 | erlotinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00795 | cetuximab | Epidermal growth factor receptor | lung cancer | view |